Ofloxacin as monotherapy in the treatment of neutropenic fever;Ofloxacino como monoterapia en el tratamiento de la fiebre neutropénica

Oncologia

Volumn 22, Issue 8, 1999, Pages 42-47

  Montalar Salcedo, J ^a   Oltra Ferrando, A ^a   Segura Huerta, A ^a   Santaballa Bertran A ^a   Yuste Izquierdo, A ^a   Aparicio Urtasun, J ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Neutropenic fever; Ofloxacin

Indexed keywords

ANTIBIOTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; OFLOXACIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE PHASE RESPONSE; ANTIBIOTIC THERAPY; ARTICLE; CANCER PATIENT; CELL COUNT; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

EID: 0033303477     PISSN: 03784835     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Management of fever in patients with cancer and treatment-induced neutropenia
2. Antibiotic therapy for the febrile granulocytopenic cancer patient: Combination therapy vs monotherapy
3. Tratamiento de los episodios neutropénicos febriles con ceftazidima o imipenem en monoterapia
4. Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients
5. Farmacocinética comparada de ofloxacino frente a otras quinolonas
6. Actividad antimicrobiana del ofloxacino
7. Intravenous ofloxacin in severe infections
8. Clinical experience with parenteral and oral ofloxacin in severe infections
9. Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients
10. Comparative pharmacokinetics and serum bactericidal activities of ciprofloxacin and ofloxacin following single dose (oral and intravenous) administration
11. Eficacia clínica y tolerancia del ofloxacino
12. Use of ofloxacin in prevention and treatment of secondary infections in hematological malignancies
13. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia
14. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy
15. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
16. Three antibiotic regimens in the treatment of infection in febril granulocytopenic patients with cancer
17. Antimicrobial therapy in cancer patients: Studies from the EORTC International Antimicrobial Therapy Cooperative Group
18. Guidelines for use of antimicrobial agents in neutropenic patients with unexplained fever
19. Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: A meta-analysis
20. Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: An overview
21. Infections in the cancer patient
22. Filgastrim in patients with chemotherapy-induced febrile neutropenia: A doble-blind, placebo-controlled trial